Awards partner life science researchers with industries

Reducing antibiotic resistance in animals and developing a lubricating formula in joints for people suffering from arthritis are two of seven projects that received Center for Advanced Technology annual grants.

Cellular signaling pathway contributes to cancers

A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.

Binding molecule could improve injected radiation therapy

A group led by assistant professor Justin Wilson has developed a binding molecule that could improve targeted alpha-particle therapy - injected radiation treatment - for prostate cancer patients.

Symposium highlights Alzheimer’s research breakthroughs

Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases according to experts at the Appel Alzheimer’s Disease Research Institute Symposium.

New technique captures real-time movies of a molecular pump

Scientists have captured the first video recordings of a key protein whose function is essential to a deadly foodborne bacteria.

Dr. Anthony Hollenberg appointed chairman of medicine at Weill Cornell Medicine

Dr. Anthony Hollenberg has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine.

2018 eLab startups reflect interdisciplinary entrepreneurship

Cornell’s business accelerator for student startups, eLab, recently announced its 2017-18 cohort of 15 startups.

Dogs offer new hope for lymphoma research

New research to improve the effectiveness of promising new cancer treatments could prove mutually beneficial to both dogs and people.

Transplantation of young blood vessel cells boosts aging stem cells

Transplanting young blood vessel cells into older mice can make their aged stem cells take on the characteristics of young stem cells.